What is the price target for VIGL stock?
13 analysts have analysed VIGL and the average price target is 8.16 USD. This implies a price increase of 1.37% is expected in the next year compared to the current price of 8.05.
NASDAQ:VIGL • US92673K1088
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIGIL NEUROSCIENCE INC (VIGL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-05-27 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-05-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-05-22 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-05-22 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-05-05 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-14 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-04 | William Blair | Initiate | Outperform |
| 2024-11-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Guggenheim | Maintains | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-06-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-04-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 237.21% | N/A -10.98% | N/A 108.63% | N/A 50.30% | N/A 85.30% | N/A 39.62% | ||||||
| EBITDA YoY % growth | -27.21M | -42.38M -55.75% | -68.8M -62.34% | -88.467M -28.59% | -89.23M -0.86% | N/A -33.74% | N/A -30.39% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.21M | -42.41M -55.86% | -68.88M -62.41% | -88.866M -29.02% | -89.683M -0.92% | N/A -12.78% | N/A -18.05% | N/A -39.08% | N/A -1.75% | N/A 43.41% | N/A 18.67% | N/A 112.99% | N/A 460.87% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -2.19 13.07% | -2.13 2.74% | -2.06 3.29% | N/A 20.49% | N/A -13.23% | N/A -16.60% | N/A 112.26% | N/A 142.31% | N/A 63.49% | N/A -0.97% | N/A 65.69% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.45 4.85% | -0.46 19.09% | -0.43 12.57% | -0.63 -12.93% | -0.69 -55.10% | -0.75 -63.67% |
| Revenue Q2Q % growth | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -25.593M -23.78% | -26.685M -6.26% | -27.862M -18.72% | N/A | N/A | N/A |
All data in USD
13 analysts have analysed VIGL and the average price target is 8.16 USD. This implies a price increase of 1.37% is expected in the next year compared to the current price of 8.05.
VIGIL NEUROSCIENCE INC (VIGL) will report earnings on 2025-11-03.
The consensus EPS estimate for the next earnings of VIGIL NEUROSCIENCE INC (VIGL) is -0.45 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering VIGIL NEUROSCIENCE INC (VIGL) is 13.